Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) insider Edwin Reisz sold 50,000 shares of the business’s stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total value of $575,000.00. Following the transaction, the insider directly owned 1,397,897 shares in the company, valued at $16,075,815.50. The trade was a 3.45% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Aveanna Healthcare Trading Up 0.2%
AVAH stock opened at $13.62 on Thursday. Aveanna Healthcare Holdings Inc. has a one year low of $5.93 and a one year high of $13.98. The stock has a market cap of $2.97 billion, a price-to-earnings ratio of 11.07, a price-to-earnings-growth ratio of 0.85 and a beta of 1.90. The company has a fifty day moving average price of $9.95 and a two-hundred day moving average price of $8.03. The company has a debt-to-equity ratio of 4.47, a current ratio of 1.16 and a quick ratio of 1.16.
Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last issued its quarterly earnings data on Thursday, August 13th. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.05. The company had revenue of $670.48 million for the quarter, compared to analyst estimates of $638.61 million. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. Equities analysts anticipate that Aveanna Healthcare Holdings Inc. will post 0.75 EPS for the current year.
Institutional Investors Weigh In On Aveanna Healthcare
Wall Street Analysts Forecast Growth
Several equities analysts have recently commented on the company. Wall Street Zen downgraded Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 15th. Royal Bank Of Canada boosted their price target on Aveanna Healthcare from $10.00 to $16.00 and gave the company an “outperform” rating in a research note on Monday. Barclays upped their price objective on Aveanna Healthcare from $9.00 to $9.50 and gave the company an “overweight” rating in a report on Thursday, July 9th. Raymond James Financial increased their price objective on Aveanna Healthcare from $13.00 to $15.00 and gave the stock a “strong-buy” rating in a research report on Friday, August 14th. Finally, Truist Financial boosted their target price on shares of Aveanna Healthcare from $11.00 to $15.00 and gave the company a “hold” rating in a research report on Monday. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $12.89.
View Our Latest Analysis on Aveanna Healthcare
About Aveanna Healthcare
Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.
In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.
Featured Articles
- Five stocks we like better than Aveanna Healthcare
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
